Dr. Jay Battacharya, a Stanford University physician and economist is uniquely positioned to have a balanced and informed perspective on coronavirus and the extreme lockdown of the economy. He makes many of the same points that I have been trying to make in my posts, but is much more knowledgeable and articulate. He wrote an editorial in the Wall Street Journal, (WSJ Comm.) and here is a great interview he has given (interview). Please watch and please share as widely as you can. Please note that he particularly emphasizes the need to get this random population sampling done, which should be both antibody and infection testing, so that we have better information about what the real infection rate and mortality rate of coronavirus are. And he also strongly emphasizes that on the other side of the balance scale, the economic lockdown and resulting depression will cost millions of lives.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Now here is a tale from the glory days of epidemic investing, as the Feds pumped trillions into the economy and a lot of it went to investing, some to...
January 10, 2023
Another merger of two struggling “digital” health companies, which use virtual reality as a product design. Apparently you are less likely to drown in high seas when you are holding...
December 18, 2022
Mercer, a large benefits consulting firm, confirms that health plan premiums are rising in 2023, publishing survey results showing that employers expect an increase of costs by at least 5%....
December 9, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace